5-Bromo-2'-deoxycytidine; 1022-79-3; 4-Amino-5-bromo-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one; Bromodeoxycytidine; 5-Bromodeoxycytidine; Brcdr; 6M3TP1AIBH; CYTIDINE, 5-BROMO-2'-DEOXY-; BCDR; 5-bromo-2'-deoxycytidine monohydrate; 4-amino-5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one; C9H12BrN3O4; 4-Amino-5-bromo-1-((2R,4S,5R)-4-hydroxy-5-(hydroxy-methyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one; UNII-6M3TP1AIBH; 5-bromo-2'-deoxy-d-cytidine; NSC-61765; 5-Bromo-dCrd; 4-AMINO-5-BROMO-1-((2R,4S,5R)-4-HYDROXY-5-(HYDROXYMETHYL)OXOLAN-2-YL)PYRIMIDIN-2-ONE; EINECS 213-824-2; MFCD00047496; NSC 61765; BRN 0027385; C.A.S. 1,022,793; 4-25-00-03689 (Beilstein Handbook Reference); 5-bromo-2'-doxy-D-cytidine; SCHEMBL197813; CHEMBL386413; HG1358; ZINC17322984; AKOS015833979; AKOS016001310; CS-W012092; AC-32305; AS-59077; A855744; Q27265134; 4-amino-5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one; 4-amino-5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one; 5BT